• Home
  • Recruiting Trials

Recruiting Trials

Research Area
Study Name
Basic Eligibility
Doctors Referral
Participant Enquiry

Research Area:
Viral Respiratory Disease
Study Name:
SHIVERS
Basic Eligibility:
Viral respiratory disease
Acute presentation to Middlemore Emergency Department or Intensive care unit
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients with acute presentation at Middlemore Hospital.

Research Area:
Rheumatic Fever
Study Name:
Start
Basic Eligibility:
Aged between 5 - 14 years
Newly diagnosed with Acute rheumatic fever
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Research Area:
Giant Cell Arthritis
Study Name:
Select - GCA (M16-852)
Basic Eligibility:
Age 50 or over
Diagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Cardiology

Research Area:
Cardiology
Heart Failure
Study Name:
SODIUM-HF
Basic Eligibility:
Age 18 or over
Confirmed diagnosis of Heart Failure
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Cardiology
Acute Coronary Syndrome
Study Name:
AEGIS-II (CSL112_3001)
Basic Eligibility:
Type 1 Myocardial infarction
Have at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Diabetes

Research Area:
Diabetes
Diabetic Kidney Disease
Study Name:
Type 2 Diabetes / Chronic Kidney Disease
Basic Eligibility:
Are you aged ≥18 ≤79?
Have been receiving stable treatment for your diabetes and diabetic kidney disease for the past 3 months?
Are you able to participate in a study for up to 26 weeks?
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Diabetes
Type 2 Diabetes
Study Name:
Scohia - CT19649
Basic Eligibility:
Age between 18 - 75
Diabetic Kidney Disease
Type 2 Diabetes
HbA1c less than 10.5% (≤ 91 mmol/mol)
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Diabetes
Type 2 Diabetes
Study Name:
DeLIVER
Basic Eligibility:
Are you aged between 22 and 70?
Have you been diagnosed with Type 2 Diabetes?
Are you on a consistent drug regimen of Metformin or Metformin/Vildagliptin only?
Do you have a waist circumference ≥102 cm (male) and ≥88 cm (female)?
Have you been diagnosed with hypertension:SBP ≥140 mmHg OR on ≤2 hypertension medications with SBP ≥130 mmHg?
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Diabetes
Type 2 Diabetes/Obesity
Study Name:
Adolescent Bariatric Study
Basic Eligibility:
Aged between 15 years 9 months and 18
Obesity with a BMI >35
Diagnosed with either pre-diabetes or type 2 diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Gastroenterology/Hepatology

Research Area:
Gastroenterology/Hepatology
Fatty Liver
Study Name:
AURORA (3152-301-002)
Basic Eligibility:
Aged 18 - 75 years
Diagnosed with NASH or ‘Fatty Liver’
Do not have HIV, Cirrhosis, Hepatitis B or C
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Gastroenterology/Hepatology
Chronic Hepatitis B
Study Name:
DCR-HBVS-101, GS-US-493-5342, VIR (VIR-2218), YP (YP39364)
Basic Eligibility:
Age 18 to 65
Chronic Hepatitis B infection
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Gastroenterology/Hepatology
Chronic Hepatitis B
Study Name:
Piranga [WV41073 (CHB)]
Basic Eligibility:
Aged 18 to 65
Chronic Hepatitis B infection
On stable NUC treatment (e.g Entecavir orTenofovir)
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Haematology

Research Area:
Haematology
Follicular Lymphoma
Study Name:
FL212 (BGB-3111-212)
Basic Eligibility:
Age over 18 years
Diagnosed Follicular Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Haematology
Multiple Myeloma
Study Name:
KIWI
Basic Eligibility:
Age over 18
Newly diagnosed Symptomatic Multiple Myeloma
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Haematology
Myelodysplastic Syndrome (MDS)
Study Name:
KER050 (Anemia in MSD)
Basic Eligibility:
Age ≥ 18
Diagnosed with Myelodysplastic Syndrome (MDS)
Anemia
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Haematology
Myelofibrosis
Study Name:
MOMENTUM (SRA-MMB-301)
Basic Eligibility:
Age over 18
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis
Previously treaded with Ruxolitinib
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Haematology
Lymphoma - Non-Hodgkins
Study Name:
B-MIND
Basic Eligibility:
Aged 18 years or older
Confirmed diagnosis of DLBCL
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Haematology
Essential Thrombocythemia
Study Name:
IMG-7289-CTP-201
Basic Eligibility:
Age ≥ 18
Diagnosis of Essential Thrombocythemia
Failure of standard therapy, e.g. Hydroxyurea
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Neonatal

Research Area:
Neonatal
Neonatal care
Study Name:
PAEAN
Basic Eligibility:
Infants born at or more than 35 weeks
Indication of perinatal depression
Moderate to severe encephalopathy
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.

Respiratory

Research Area:
Respiratory
Chronic obstructive pulmonary disease
Study Name:
PACE
Basic Eligibility:
Aged between 40 and 85 years
Diagnosed with COPD
A history of cardiovascular disease, including heart failure, ischaemic heart disease, tachyarrhythmias, and hypertension
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Respiratory
Bronchiectasis
Study Name:
Resveratrol
Basic Eligibility:
Aged over 18 years
Confirmed diagnosis of bronchiectasis within 5 years
Pulmonary exacerbation requiring antibiotics in the past 12 months
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Rheumatology

Research Area:
Rheumatology
Ankylosing Spondylitis/Axial Spondyloarthritis
Study Name:
Ankylosing Spondylitis/Axial Spondyloarthritis
Basic Eligibility:
Aged 18 years or older
Diagnosis of Ankylosing Spondylitis or Axial Spondyloarthritis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

About Us

Middlemore Clinical Trials (MMCT) is New Zealand's largest clinical trials site, which offers world-class facilities, excellent audited procedures, and a fully integrated research unit.

Our Contacts